A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Laboratoires Thea
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
No patients with other ophthalmic diseases than DED
Chronic dry eye defined as longer than six months since diagnosis
OSDI score \> 22
Conjunctival Hyperemia ≥ Grade 3 (Efron Scale)
Current use of tear substitutes for at least 3 months not to be considered as sufficient by the investigator/treating physician
Need to add cyclosporine eye drops to tear substitutes as judged by the investigator/treating physician
You may not be if
Far best corrected visual acuity \< 1/10
Severe Dry Eye associated with:
* Eyelid malposition
* Stevens Johnson Syndrome
* Corneal dystrophy
* Ocular neoplasia
* Filamentous keratitis
* Corneal neovascularisation
* Orbital radiotherapy
* Dry eye related to Graft Versus Host Disease (GVHD)
History of any of the following within last 3 months:
Systemic treatment of dry eye
Systemic treatment of Meibomian Gland Dysfunction (MGD)
Isotretinoïde,
Cyclosporine,
Tacrolimus, Siromilus, Pimecrolimus
Punctual plugs
History of any of the following within previous six months:
ocular trauma
ocular infection, Ocular allergy
History of any of the following within last 12 months:
inflammatory corneal ulcer
Herpetic eye infection
or uveitis
Ocular surgery
Known hypersensitivity to any of the components of the medical product under investigation or other study medication
Pregnant or breast-feeding woman.
Woman of childbearing potential (neither menopausal, nor hysterectomized, nor sterilized) not using effective contraception (i.e. hormonal contraceptives, intra-uterine device, contraceptive implant or condoms with spermicide)
Inability of patient to understand the investigation procedures and thus inability to give valid, informed consent.
Non-compliant patient (e.g. not willing to attend the follow-up visits, way of life interfering with compliance)
Participation in another clinical study or clinical investigation at the same time as the present investigation
Participation to the present clinical investigation during the exclusion period of another clinical study
Patient already included once in this clinical investigation